Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kura Oncology (KURA) EBT Margin: 2024-2025

Historic EBT Margin for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to 357.19%.

  • Kura Oncology's EBT Margin fell 1356204.00% to 357.19% in Q3 2025 from the same period last year, while for Sep 2025 it was 431.50%, marking a year-over-year change of. This contributed to the annual value of 319.15% for FY2024, which is 1017266.00% down from last year.
  • According to the latest figures from Q3 2025, Kura Oncology's EBT Margin is 357.19%, which was up 17.42% from 432.51% recorded in Q2 2025.
  • In the past 5 years, Kura Oncology's EBT Margin ranged from a high of 13,204.85% in Q3 2024 and a low of 432.51% during Q2 2025.